These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 649448)
1. Tumor immunology and immunotherapy of malignant disease: Part 1. Staab RC J Am Osteopath Assoc; 1978 Apr; 77(8):624-36. PubMed ID: 649448 [No Abstract] [Full Text] [Related]
2. Tumor immunology and immunotherapy of malignant disease: Part 2. Staab RC J Am Osteopath Assoc; 1978 May; 77(9):712-6. PubMed ID: 649454 [No Abstract] [Full Text] [Related]
3. How should clinical data be included in experimental studies of cancer immunology? Gjertsen BT; Bruserud Ø Cancer Immunol Immunother; 2004 Aug; 53(8):677-80. PubMed ID: 15069584 [TBL] [Abstract][Full Text] [Related]
4. [Is tumor immunology significant when the major part of spontaneous tumors are non immunogenic?]. Forni G; Giovarelli M Ric Clin Lab; 1985; 15 Suppl 2():25-30. PubMed ID: 4095455 [TBL] [Abstract][Full Text] [Related]
5. Tumor immunology at the service of cancer immunotherapy. Finn OJ Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402 [No Abstract] [Full Text] [Related]
6. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology? Fry TJ; Lankester AC Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of malignant disease (Part 2). MacGregor AB; Falk RE J R Coll Surg Edinb; 1976 Jan; 21(1):43-9. PubMed ID: 765453 [No Abstract] [Full Text] [Related]
8. [Possibilities and limitations of immunotherapy in the treatment of malignant neoplasms]. Chapuis B; Barrelet L; Dialdas J Schweiz Med Wochenschr; 1978 Dec; 108(49):1935-8. PubMed ID: 749189 [TBL] [Abstract][Full Text] [Related]
9. Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancer. Chouaib S; Meslin F; Thiery J; Mami-Chouaib F Clin Immunol; 2009 Jan; 130(1):34-40. PubMed ID: 19013109 [TBL] [Abstract][Full Text] [Related]
10. The promise of T-lymphocyte immunotherapy for the treatment of malignant disease. Thomas AK; June CH Cancer J; 2001; 7 Suppl 2():S67-75. PubMed ID: 11777267 [TBL] [Abstract][Full Text] [Related]
17. [Modern aspects of tumor immunology]. Warnatz H Med Welt; 1978 Oct; 29(41):1616-20. PubMed ID: 692357 [No Abstract] [Full Text] [Related]
18. [Tumor immunology. General survey, diagnostic and prognostic aspects, immunotherapy]. Thunold S; Orjasaeter H; Engeset A Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1862-7. PubMed ID: 4129133 [No Abstract] [Full Text] [Related]
19. The spontaneous regression of neoplasms in mammals: possible mechanisms and their application in immunotherapy. Bodey B; Bodey B; Siegel SE; Kaiser HE In Vivo; 1998; 12(1):107-22. PubMed ID: 9575433 [TBL] [Abstract][Full Text] [Related]
20. A primer on cancer immunology and immunotherapy. Lotze MT; Papamichail M Cancer Immunol Immunother; 2004 Mar; 53(3):135-8. PubMed ID: 14740175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]